PortfoliosLab logoPortfoliosLab logo
GERM vs. PBPH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GERM vs. PBPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Treatments, Testing and Advancements ETF (GERM) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*

PBPH

1D
0.58%
1M
0.07%
YTD
-1.13%
6M
-0.02%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GERM vs. PBPH - Yearly Performance Comparison


Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GERM vs. PBPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

GERM vs. PBPH - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


GERMPBPHDifference

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.04

Drawdowns

GERM vs. PBPH - Drawdown Comparison

The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum PBPH drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for GERM and PBPH.


Loading charts...

Drawdown Indicators


GERMPBPHDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-11.10%

+11.10%

Max Drawdown (1Y)

Largest decline over 1 year

0.00%

Current Drawdown

Current decline from peak

0.00%

-8.69%

+8.69%

Average Drawdown

Average peak-to-trough decline

0.00%

-4.23%

+4.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.00%

Volatility

GERM vs. PBPH - Volatility Comparison


Loading charts...

Volatility by Period


GERMPBPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.00%

Volatility (6M)

Calculated over the trailing 6-month period

0.00%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

16.78%

-16.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

16.78%

-16.78%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

16.78%

-16.78%

GERM vs. PBPH - Expense Ratio Comparison

GERM has a 0.68% expense ratio, which is higher than PBPH's 0.13% expense ratio.


Dividends

GERM vs. PBPH - Dividend Comparison

GERM has not paid dividends to shareholders, while PBPH's dividend yield for the trailing twelve months is around 0.09%.


Frequently Asked Questions


On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.

PBPH is cheaper with a 0.13% expense ratio, compared with 0.68% for GERM.

PBPH has the higher dividend yield at 0.09%, compared with 0.00% for GERM.

GERM tracks Prime Treatments, Testing and Advancements Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: Amplify and Portfolio Building Block. Their fees differ too: 0.68% for GERM and 0.13% for PBPH.

Portfolio Optimizer

Find the right allocation for GERM and PBPH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer